Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Ron T. Gansevoort; Mustafa Arici; Thomas Benzing; Henrik Birn; Giovambattista Capasso; Adrian Covic; Olivier Devuyst; Christiane Drechsler; Kai-Uwe Eckardt; Francesco Emma; Bertrand Knebelmann; Yannick Le Meur; Ziad A. Massy; Albert C.M. Ong; Alberto Ortiz; Franz Schaefer; Roser Torra; Raymond Vanholder; Andrzej Więcek; Carmine Zoccali; Wim Van Biesen

doi:10.1093/ndt/gfv456

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Ron T. Gansevoort ¹ Mustafa Arici ² Thomas Benzing ^{3, 4} Henrik Birn ^{5, 6} Giovambattista Capasso ⁷ Adrian Covic ⁸ Olivier Devuyst ^{9, 10, 11} Christiane Drechsler ¹² Kai-Uwe Eckardt ¹³ Francesco Emma ¹⁴ Bertrand Knebelmann ¹⁵ Yannick Le Meur ^{16, 17} Ziad A. Massy ^{18, 19, 20} Albert C.M. Ong ²¹ Alberto Ortiz ^{22, 23} Franz Schaefer ²⁴ Roser Torra ^{25, 26} Raymond Vanholder ²⁷ Andrzej Więcek ^{25, 28} Carmine Zoccali ²⁹ Wim Van Biesen ³⁰

1 Department of Nephrology

2 Department of Nephrology Ankara

3 Department of Medicine and Centre for Molecular Medicine

4 Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases

5 Department of Renal Medicine Aarhus

6 Department of Biomedicine Aarhus

7 INGV-Palermo

8 Nephrology Clinic Dialysis and Renal Transplant Center, Iasi

9 Institute of Physiology

10 Klinik für Nephrologie

11 Division of Nephrology

12 University College of Dublin

13 Department of Nephrology and Hypertension

14 Division of Nephrology and Dialysis

15 Department of Nephrology Hôpital Necker Paris

16 CHRU - Service de néphrologie, dialyse et transplantation rénale

17 EA2216 - Immunologie et Pathologie

18 Mécanismes physiologiques et conséquences des calcifications cardiovasculaires: rôle des remodelages cardiovasculaires et osseux

19 UPJV - Université de Picardie Jules Verne

20 CESP - Centre de recherche en épidémiologie et santé des populations

21 CSTJF - TOTAL-Scientific and Technical Center Jean Féger

22 RS2M - Département Réseaux et Services Multimédia Mobiles

23 SAMOVAR - Services répartis, Architectures, MOdélisation, Validation, Administration des Réseaux

24 Division of Pediatric Nephrology

25 Inherited Kidney Diseases Nephrology Department, Barcelona

26 REDINREN, Barcelona

27 Nephrology Section [Ghent]

28 Department of Nephrology Katowice

29 CNR-IFC Clinical Epidemiology and Pathophysiology of Renal Diseases and Hpertension Unit, Reggio Calabria

30 Renal Division, Ghent

Type de document :

Article dans une revue

Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2015, 〈10.1093/ndt/gfv456〉

Domaine :

Sciences du Vivant [q-bio] / Immunologie

Liste complète des métadonnées

http://hal.univ-brest.fr/hal-01267538
Contributeur : Geneviève Michel <>
Soumis le : jeudi 4 février 2016 - 15:23:24
Dernière modification le : mercredi 24 janvier 2018 - 15:58:41

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Lien texte intégral

Identifiants

Collections

Citation

Exporter

Métriques

138

Contact

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Lien texte intégral

Identifiants

Collections

Citation

Exporter

Partager

Métriques

138

Contact